Edwards Martin

DirectorVerona Pharma plc (VRNA) · full profile →Form 4 · filed Oct 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
3 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Disposed to issuer(D)158K0
Oct 7, 2025Disposed to issuer(D)72K0
Oct 7, 2025Option exercise(M)72K72K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2025Disposed to issuer(D)96K0
Oct 7, 2025Disposed to issuer(D)240K0
Oct 7, 2025Disposed to issuer(D)200K0
Oct 7, 2025Option exercise(M)72K0
Oct 7, 2025Disposed to issuer(D)64K0

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-097948) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.